Skip to main
ALUR
ALUR logo

ALUR Stock Forecast & Price Target

ALUR Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 75%
Buy 0%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Allurion Technologies Inc. is poised for significant growth, with projections indicating revenue could reach $51.5 million by 2025, driven by the anticipated market entry and the strong efficacy of its CE-Marked intragastric balloon, which has demonstrated fewer adverse events than competitors. The company has also made notable improvements in its cash burn, positioning itself for financial stability while its AI-powered Virtual Care Suite (VCS) opens up further revenue streams, which enhances its growth prospects. Moreover, successful reimbursement agreements could expand Allurion's addressable market by up to 30% by the end of 2024, underscoring the potential for increased market share as demand for non-drug-based weight loss solutions rises among patients and healthcare providers.

Bears say

Allurion Technologies has reported significant declines in revenue, with a sequential decrease of 55% in 4Q23, leading to total revenue of only $5.4 million, a 70% decline compared to the same quarter in the prior year. The company's management has cited several challenges, including macroeconomic factors, increased competition from GLP-1 medications, and operational issues such as destocking and reduced sales in light of credit risk management. Furthermore, Allurion has consistently experienced operating losses since inception and has been compelled to lower its full-year 2024 revenue guidance while initiating a restructuring plan aimed at cutting operating expenses by 50% in the upcoming year, indicating persistent financial instability.

ALUR has been analyzed by 4 analysts, with a consensus rating of Buy. 75% of analysts recommend a Strong Buy, 0% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Allurion Technologies Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Allurion Technologies Holdings Inc (ALUR) Forecast

Analysts have given ALUR a Buy based on their latest research and market trends.

According to 4 analysts, ALUR has a Buy consensus rating as of Jul 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $6.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $6.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Allurion Technologies Holdings Inc (ALUR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.